Aenova is one of the leading contract development and manufacturing organizations (CDMOs) in the global pharmaceutical supply chain. They provide services covering the entire value chain from development to commercialization for all common product groups and dosage forms (solid, semisolid, sterile, and nonsterile liquid). The company supplies drugs up to OEB 5 and food supplements for both human and veterinary use. They are also able to handle differentiated technologies such as HPAPI containment, low-dose, modified release formulations, organic granulation, particulate systems, lipid-based formulas, HME or spray drying for poorly soluble compounds. Aenova develops, produces and packages across a network of 14 sites. A highly motivated international team of nearly 4,000 employees from over 50 nations contributes to the group’s strong, long-lasting customer partnerships and continuous development.
For more information see www.aenova-group.com